PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX and nab-paclitaxel (FA) and nab-paclitaxel and gemcitabine (AG) as neoadjuvant therapy for (borderline) resectable pancreatic cancer (PC), focusing on biomarker and liquid biopsy...
| Autor: | Grose, Derek B., Jamieson, Nigel Balfour, Radhakrishna, Ganesh, Hawkins, Maria A., McIntosh, David, Duffton, Aileen, Graham, Janet Shirley, Goody, Rebecca, Houston, Peter, Bradley, Sarah, Ravikumar, Reena, Christie, Alan, Dixon-Hughes, Judith, Kelly, Caroline, Paterson, Lucy, Biankin, Andrew V., McKay, Colin J., Chang, David Kuang-Fu |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p669-669, 117p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|